Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

tacrolimus

tacrolimus
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Hecoria, Prograf CAPSULE, ORAL 0.5 mg, 1 mg, 5 mg      
Prograf SOLUTION, INTRAVENOUS 5 mg/mL      
Envarsus XR TABLET, EXTENDED RELEASE, ORAL 0.75 mg, 1 mg, 4 mg    
VIEW MORE Miscellaneous Therapeutic Agents
Comments:

Envarsus XR should be interchanged to tacrolimus immediate release on a 1 mg: 1.25-1.42 mg ratio based on total daily dose (TDD) then rounded to the nearest dosage form(s) available in divided doses.

Examples:

  • Envarsus XR 1 mg daily ---> Prograf 1.25 mg - 1.42 mg TDD ---> Prograf 0.5 mg TID
  • Envarsus XR 4 mg daily ---> Prograf 5 mg - 5.71 mg TDD ---> Prograf 3 mg qAM + 2 mg qPM

 

Reviewed: Sept. 2022 (Envarsus XR)

Tacolimus extended release (Envarsus XR)

Last updated: Feb. 3, 2025
Rhazdrugs tacrolimus






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved